Foundation Medicine, Inc., a precision medicine company transforming lives in cancer care and beyond, announced a partnership with Manifold, the leading artificial intelligence (AI) data platform for life sciences, to bring enhanced AI capabilities to FoundationInsights, a cloud-based data analytics and visualization platform that derives insights from Foundation Medicine’s proprietary multimodal datasets.
Health Technology Insights: CareDx Names Jeffrey Teuteberg as Chief Medical Officer
The enhanced version of FoundationInsights is now available for biopharmaceutical partners and provides users the flexibility needed to seamlessly answer important questions during the drug development process. The additional power of Manifold’s AI data platform enables FoundationInsights to offer a faster, more intuitive approach to extract insights from Foundation Medicine’s proprietary dataset of de-identified genomic results from more than 800,000 patients.
Health Technology Insights: Wellpoint DC Earns First NCQA Accreditation with Perfect Score
FoundationInsights provides users the ability to rapidly identify groups of patients or explore the prevalence of genomic alterations. AI-enabled simple, natural language searches enable users to easily set complex genomic criteria. For deeper insights, technical users can perform in-depth, customized analyses using popular programming languages, such as Python and R.
“Foundation Medicine is using AI and machine learning to power our real-world data solutions to accelerate drug discovery and development. With new AI-powered capabilities from Manifold, biopharmaceutical partners can find the answers needed to make decisions faster than ever before,” said Troy Schurr, chief biopharma business officer at Foundation Medicine. “Our partners now have a one-stop shop to easily access comprehensive multimodal data from Foundation Medicine combined with advanced analytics and visualization tools, so patients can benefit from advances in precision medicine.”
“Foundation Medicine is a pioneer in precision diagnostics,” said Vinay Seth Mohta, chief executive officer and co-founder at Manifold. “By combining Foundation Medicine’s powerful multimodal databases with Manifold’s purpose-built AI capabilities for life sciences, together we can make it easier for researchers to work smarter and faster to unlock the answers needed to discover innovative personalized therapies.”
FoundationInsights powered by Manifold is now available to biopharmaceutical partners, with plans to launch a customized version for healthcare providers and health systems in 2026.
Health Technology Insights: Bristol Myers Squibb Showcases Sotyktu Data in PsA and Lupus Studies
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
Source- businesswire
